# Acute Effects of the Prostaglandin (Alprostadil) on Cerebral and Pulmonary Flow

> **NCT04054115** · PHASE1 · TERMINATED · sponsor: **The Hospital for Sick Children** · enrollment: 10 (actual)

## Conditions studied

- Congenital Heart Disease

## Interventions

- **DRUG:** Alprostadil 5 MCG Injection

## Key facts

- **NCT ID:** NCT04054115
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-07-23
- **Primary completion:** 2021-02-24
- **Final completion:** 2022-11-09
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Covid 19 and difficulty with recruitment
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04054115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04054115, "Acute Effects of the Prostaglandin (Alprostadil) on Cerebral and Pulmonary Flow". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04054115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*